Amyotrophic Lateral Sclerosis
6 competing products in clinical development for Amyotrophic Lateral Sclerosis.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 23
Phase 31
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| methylcobalamin + saline solution | Eisai | Phase 3 | Completed | 40 |
| Reldesemtiv + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| ZYIL1 capsules 25 mg and 50 mg Placebo + ZYIL1 capsules 50 mg and 25 mg Placebo + ZYIL1 capsules 25 mg and ZYIL1 capsules 50 mg + Matching placebo 25 mg and Matching placebo 50 mg | Zydus Lifesciences | Phase 2 | Completed | 35 |
| 89Zr-DFO-AP-101 | Eli Lilly | Phase 1 | Active | 33 |
| Perampanel + Placebo Oral Tablet | Eisai | Pre-clinical | Terminated | 18 |
| AL001 + Placebo | Alector | Phase 2 | Terminated | 17 |